| Literature DB >> 29890638 |
Neil J Hime1,2, Guy B Marks3,4,5, Christine T Cowie6,7,8.
Abstract
This article briefly reviews evidence of health effects associated with exposure to particulate matter (PM) air pollution from five common outdoor emission sources: traffic, coal-fired power stations, diesel exhaust, domestic wood combustion heaters, and crustal dust. The principal purpose of this review is to compare the evidence of health effects associated with these different sources with a view to answering the question: Is exposure to PM from some emission sources associated with worse health outcomes than exposure to PM from other sources? Answering this question will help inform development of air pollution regulations and environmental policy that maximises health benefits. Understanding the health effects of exposure to components of PM and source-specific PM are active fields of investigation. However, the different methods that have been used in epidemiological studies, along with the differences in populations, emission sources, and ambient air pollution mixtures between studies, make the comparison of results between studies problematic. While there is some evidence that PM from traffic and coal-fired power station emissions may elicit greater health effects compared to PM from other sources, overall the evidence to date does not indicate a clear ‘hierarchy’ of harmfulness for PM from different emission sources. Further investigations of the health effects of source-specific PM with more advanced approaches to exposure modeling, measurement, and statistics, are required before changing the current public health protection approach of minimising exposure to total PM mass.Entities:
Keywords: air pollution; health effects; particulate matter; source-specific
Mesh:
Substances:
Year: 2018 PMID: 29890638 PMCID: PMC6024892 DOI: 10.3390/ijerph15061206
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Results of search of scientific databases.
Conclusions from previous reviews of the differences in the health effects of different components and sources of PM air pollution.
| Reference | Study Conclusions in Relation to Health Effects of Source-Specific PM Air Pollution |
|---|---|
| [ | The black carbon, for which vehicles and particularly diesel vehicles are a major source in urban areas, in PM might make PM from those sources the most harmful. |
| [ | Current evidence does not allow a precise differentiation to be made as to which constituents or sources of PM are most closely related to specific health outcomes. However, three components, black carbon, secondary organic aerosols, and secondary inorganic aerosols may be important contributors to PM toxicity. |
| [ | Current knowledge does not allow precise quantification or definitive ranking of the health effects of PM from different sources. However, some results suggest that a range of serious health effects are more consistently associated with traffic-related PM and specific metals and elemental carbon in PM. |
| [ | There is a lack of information by which to differentiate the toxicity of different components of PM. |
| [ | Evidence suggests that carbon components and several metals in PM are associated with health effects however it is unclear whether these components are responsible for health impacts or they are surrogates for other pollutants. |
| [ | Cardiovascular health effects may be associated with PM2.5 from crustal or combustion sources, including traffic, but at this time, no consistent relationships have emerged. Collective evidence has not yet isolated factors or sources that would be closely and unequivocally related to specific health outcomes. |
| [ | There is evidence that metals within PM affect health but considerable uncertainties about causality remain. |
| [ | Evidence relating to the toxicity of inorganic components of PM2.5 is not consistent. Crustal components of PM2.5 are not likely, by themselves, to be a significant health risk. |
| [ | Public health will likely be better protected by reduction of various vehicular emissions than by regulation of total PM2.5 mass as if all PM2.5 is equitoxic. However, the knowledge base is incomplete. |
| [ | There is little support for the idea that any single major or trace component of PM is responsible for the adverse health effects of PM. |
Source-apportionment studie s that compared the health effects of different source-specific PM2.5 within studies.
| Ref. | Method Used to Identify Source-Specific PM | Health Outcomes Investigated | Relative Risk Associated with an Increase in PM2.5 (95% Confidence Interval) 1 | |||||
|---|---|---|---|---|---|---|---|---|
| Source | Traffic | Coal-Fired Power Stations (Secondary Sulphate) | Diesel Exhaust | Wood Smoke | Crustal Dust (Soil) | All (Total Mass) | ||
| [ | Factor analysis to identify up to 5 common factors from 15 specified elements | Daily all-cause mortality per 10 µg/m3 increase in PM2.5 | 1.03 (no CI’s) | 1.05 (no CI’s) | ||||
| [ | Factor analysis to identify up to 5 common factors from 15 specified elements | Daily all-cause mortality per 10 µg/m3 increase in PM2.5 | 1.034 (1.017–1.052) | 1.011 (1.003–1.020) | 0.977 (0.942–1.012) | 1.016 (1.011–1.021) | ||
| [ | Positive matrix factorization | Daily cardiovascular and respiratory hospital admissions per 5–95th percentile increase in PM2.5 | 1.04 (1.01–1.08) 2 (cardiovascular) 1.01 (0.97–1.06) 2 (respiratory) | 1.01 (0.97–1.05)2 (cardiovascular) 1.03 (0.97–1.09) 2 (respiratory) | 1.00 (0.95–1.04) 2 (cardiovascular) 1.02 (0.96–1.09) 2 (respiratory) | 1.01 (0.98–1.05) 2 (cardiovascular) 1.05 (1.00–1.10) 2 (respiratory) | ||
| [ | Positive matrix factorization | Daily all-cause and cardiovascular mortality per IQR increase in PM2.5 | 1.056 (1.018–1.095) (all-cause) 1.103 (1.033–1.178) (cardiovascular) | 1.019 (0.975–1.065) (all-cause) 1.072 (1.014–1.133) (cardiovascular) | 1.019 (1.008–1.031) (all-cause) 1.039 (1.019–1.060) (cardiovascular) | |||
| [ | Positive matrix factorization | Daily all-cause, cardiovascular and respiratory mortality per IQR increase in PM2.5 | 1.005 (0.993–1.017) (all-cause) 1.008 (0.986–1.031) (cardiovascular) 1.055 (1.005–1.107) (respiratory) | 1.005 (0.995–1.014) (all-cause) 1.010 (0.991–1.029) (cardiovascular) 1.021 (0.983–1.061) (respiratory) | 1.006 (0.991–1.020) (all-cause) 1.009 (0.981–1.037) (cardiovascular) 1.067 (1.002–1.137) (respiratory) | 1.001 (0.997–1.006) (all-cause) 1.003 (0.994–1.013) (cardiovascular) 1.016 (0.997–1.035) (respiratory) | 1.005 (0.992–1.019) (all-cause) 1.028 (1.002–1.054) (cardiovascular) 1.021 (0.972–1.071) (respiratory) | |
| [ | Positive matrix factorization | Daily cardiovascular and respiratory emergency department (ED) visits per IQR increase in PM2.5 | 1.022 (1.012–1.032) 2 (cardiovascular) 0.999 (0.993–1.007)2 (respiratory) | 1.004 (0.992–1.021) 2 (cardiovascular) 1.015 (1.002–1.028) 2 (respiratory) | 1.030 (1.017–1.039) 2 (cardiovascular) 0.997 (0.991–1.005) 2 (respiratory) | 1.029 (1.018–1.037) 2 (cardiovascular) 0.999 (0.993–1.006) 2 (respiratory) | 1.005 (0.998–1.012) 2 (cardiovascular) 0.998 (0.993–1.003) 2 (respiratory) | 1.025 (1.008–1.041) 2 (cardiovascular) 1.007 (0.996–1.019) 2 (respiratory) |
| [ | Various multivariate factor analysis based receptor models | Daily all-cause and cardiovascular mortality per 5–95th percentile increase in PM2.5 | 1.03 (0.98–1.07) 2 (all-cause) 1.05 (0.97–1.11) 2 (cardiovascular) | 1.07 (1.02–1.12) 2 (all-cause) 1.07 (0.99–1.14) 2 (cardiovascular) | 1.00 (0.99–1.02) 2 (all-cause) 1.01 (0.98–1.04) 2 (cardiovascular) | 1.02 (0.99–1.04) 2 (all-cause) 1.04 (1.00–1.07) 2 (cardiovascular) | ||
| [ | Various multivariate factor analysis based receptor models | Daily all-cause and cardiovascular mortality per 5–95th percentile increase in PM2.5 | 1.01 (0.90–1.12) 2 (all-cause) 1.13 (0.97–1.29) 2 (cardiovascular) | 1.03 (0.92–1.13) 2 (all-cause) 1.16 (1.00–1.31) 2 (cardiovascular) | 1.02 (0.93–1.10) 2 (all-cause) 1.09 (0.96–1.21) 2 (cardiovascular) | 1.01 (0.90–1.11) 2 (all-cause) 1.01 (0.85–1.16) 2 (cardiovascular) | Not reported (all-cause) 1.150 (1.015–1.303) (cardiovascular) | |
| [ | Multivariate factor analysis of elemental data with source modeling | All-cause, ischemic heart disease (IHD) and respiratory mortality per IQR increase in PM2.5 | 1.032 (1.021–1.042) 2 (all-cause) 1.013 (0.987–1.039) 2 (IHD) 1.09 (1.05–1.13) 2 (respiratory) | 1.008 (1.001–1.015) 2 (all-cause) 1.042 (1.024–1.060) 2 (IHD) 0.95 (0.92–0.97) 2 (respiratory) | 1.000 (0.993–1.006) 2 (all-cause) 1.000 (0.986–1.012) 2 (IHD) 1.02 (1.00–1.04) 2 (respiratory) | |||
1 Results are only shown for the emission sources covered by this review. Where a study examined the change in health outcome risk over several days of lag after the exposure to PM2.5, the result that is shown corresponds to the lag for which there was the maximum increase in the health outcome. 2 Values are approximations read from figures in the respective references.
Figure 2Forest plots of the change in all-cause and cardiovascular risk associated with increases in source-specific PM2.5. The data in these forest plots are from Table 2. The reference numbers applicable to the different data are shown.
Summary of PM emission sources and reported health and physiological/toxicity effects (physiological/toxicity effects includes animal studies).
| Emission Source | Health Risk and Reference |
|---|---|
|
| |
| Total traffic-related air pollution (TRAP) | exacerbation and onset of childhood asthma, respiratory symptoms, impaired lung function, all-cause mortality, cardiovascular morbidity [ |
| myocardial infarction [ | |
| reduced lung function in children [ | |
| increased blood pressure [ | |
| allergic sensitization [ | |
| premature birth [ | |
| Specifically traffic PM | all-cause, respiratory and cardiovascular mortality, cardiovascular, stroke and heart failure morbidity [ |
| cardiovascular toxicity and various cardiovascular effects [ | |
| cytotoxicity, pulmonary inflammation [ | |
|
| all-cause, cardiovascular, respiratory, ischaemic heart disease, pneumonia, lung cancer mortality [ |
| respiratory morbidity [ | |
| cardiovascular morbidity [ | |
|
| respiratory mortality [ |
| lung and oesophageal cancer mortality [ | |
| allergic inflammation, asthma symptoms, lung cancer [ | |
| cardiovascular morbidity [ | |
| cardiovascular changes indicative of increased coronary event risk, changes in lung function, nose and throat irritation [ | |
| atopy and susceptibility to infection [ | |
| effects on offspring from exposure during pregnancy [ | |
| respiratory symptoms and exacerbations [ | |
| cardiovascular morbidity [ | |
| respiratory morbidity [ | |
| compromised lung immunity, airway inflammation [ | |
|
| all-cause and cardiovascular mortality [ |
| respiratory mortality(>75 years of age) [ | |
| respiratory and COPD morbidity [ | |
| asthma exacerbation [ | |
| reduced lung function in children [ | |
| pneumonia [ | |
| lung inflammation [ | |
| infectious disease [ |